Abstract
Assessing the effectiveness of Non-Pharmaceutical Interventions (NPIs) to mitigate the spread of SARS-CoV-2 is critical to inform future preparedness response plans. Here we quantify the impact of 6,068 hierarchically coded NPIs implemented in 79 territories on the effective reproduction number, Rt, of COVID-19. We propose a novel modelling approach that combines four computational techniques merging for the first time statistical, inference and artificial intelligence tools. We validate our findings with two external datasets with 48,000 additional NPIs from 226 countries. Our results indicate that a suitable combination of NPIs is necessary to curb the spread of the virus. Less intrusive and costly NPIs can be as effective as more intrusive, drastic, ones, e.g., a national lockdown. Using country-specific what-if scenarios we assess how the effectiveness of NPIs depends on the local context such as timing of their adoption, opening the way for forecasting the effectiveness of future interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Austrian Science Promotion Agency, FFG project under 857136, the WWTF under COV 20-001, COV 20-017 and MA16-045, the Medizinisch-Wissenschaftlichen Fonds des Buergermeisters der Bundeshauptstadt Wien under CoVid004, and the project VET-Austria, a cooperation between the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection, the Austrian Agency for Health and Food Safety and the University of Veterinary Medicine Vienna.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data set on non-pharmaceutical interventions to curb the spread of COVID-19 is available online via the following repository: https://github.com/amel-github/covid19-interventionmeasures. The data on confirmed cases of COVID-19 has been taken from https://github.com/CSSEGISandData/COVID-19.
